AVROBIO IncAVROBIO Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Full Sustainability assessment of AVROBIO Inc can be reached by registering for free. This page contains a free ESG report covering AVROBIO Inc. The ESG score includes 17 UN Sustainable Development Goals including: 'Quality Education', 'Climate Action' and 'Life below Water'.

AVROBIO Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.9; made up of an environmental score of 3.2, social score of 1.6 and governance score of 6.7.

SDG Transparency Score for AVROBIO Inc 

3.9

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for AVROBIO Inc 
3.2

Environmental

1.6

Social

6.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
1443XSpray Pharma AB (publ)
4.0
High
1443Zhong Yuan Bio-Technology Holdings Ltd
4.0
High
.........
1476AVROBIO Inc
3.9
Medium
1476Anebulo Pharmaceuticals Inc
3.9
Medium
1476Anhui Sunhere Pharmaceutical Excipients Co Ltd
3.9
Medium
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does AVROBIO Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does AVROBIO Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does AVROBIO Inc report the average age of the workforce?

LockedSign up for free to unlock

Does AVROBIO Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does AVROBIO Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does AVROBIO Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does AVROBIO Inc offer flexible work?

LockedSign up for free to unlock

Does AVROBIO Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does AVROBIO Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does AVROBIO Inc conduct supply chain audits?

LockedSign up for free to unlock

Does AVROBIO Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does AVROBIO Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does AVROBIO Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does AVROBIO Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does AVROBIO Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does AVROBIO Inc disclose water use targets?

LockedSign up for free to unlock

Does AVROBIO Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did AVROBIO Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does AVROBIO Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does AVROBIO Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has AVROBIO Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does AVROBIO Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does AVROBIO Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does AVROBIO Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does AVROBIO Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does AVROBIO Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does AVROBIO Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does AVROBIO Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is AVROBIO Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does AVROBIO Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does AVROBIO Inc disclose its waste policy?

LockedSign up for free to unlock

Does AVROBIO Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does AVROBIO Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does AVROBIO Inc disclose energy use targets?

LockedSign up for free to unlock

Does AVROBIO Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does AVROBIO Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for AVROBIO Inc
These potential risks are based on the size, segment and geographies of the company.

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Sorry!

Failed to process!